An observational study in Vestibular Schwannoma, sponsored by Medical University of Vienna. Recruiting at 1 site in Austria. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2024-01-05.
Sponsored by Medical University of Vienna · Observational
MR Fingerprinting (MRF) will be performed in patients who will be treated with Gamma Knife radio surgery for a vestibular schwannoma before the intervention. Fifty patients will be included with a vestibular schwannoma of minimum 1cm in size. During follow-up, response of the tumor to radiosurgery will be evaluated for each patient with MRI. The aim of the study is to find patterns of vestibular schwannomas in MRF data which correlate with the type of response to radio surgery, i.e. tumor control after radiosurgery, further tumor growth despite radiosurgery, cystic transformation after radiosurgery.
82 studies on the registry are indexed under Neurilemmoma; 21 are open to participants now.
This study's planned enrollment of 50 is below the median of 63 across 30 observational studies indexed under Neurilemmoma.
Browse Neurilemmoma studies →Medical University of Vienna is the lead sponsor of 1,076 studies on the registry; 177 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with vestibular schwannoma of minimum 1cm, who will undergo Gamma Knife radiosurgery
Inclusion Criteria: Planned Gamma Knife radiosurgery for vestibular schwannoma of minimum 1cm in size -
Exclusion Criteria: Vestibular Schwannoma of less than 1cm in size. Other a priori treatment than Gamma Knife radiosurgery
-
Specific Magnetic Resonance Imaging protocol
Tumor control
Number of patients without further growth of the tumor on follow-up MRI after radiosurgery
Time frame: 3 years
Tumor growth
Number of patients with growth of the tumor on follow-up MRI after radiosurgery
Time frame: 3 years
Cystic transformation
Number of patients with cystic transformation of the tumor on follow-up MRI after radiosurgery
Time frame: 3 years
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Vienna